Severe breakthrough COVID-19 with a heavily mutated variant in a multiple myeloma patient 10 weeks after vaccination

por Stampfer, Samuel D., Goldwater, Marissa-Skye, Bujarski, Sean, Regidor, Bernard, Zhang, Wenjuan, Feinstein, Aaron J., Swift, Regina, Eshaghian, Shahrooz, Vail, Eric, Berenson, James R.
Publicado 2022

Third dose of an mRNA COVID-19 vaccine for patients with multiple myeloma

por Goldwater, Marissa-Skye, Stampfer, Samuel D., Sean Regidor, Bernard, Bujarski, Sean, Jew, Scott, Chen, Haiming, Xu, Ning, Kim, Clara, Kim, Susanna, Berenson, James R.
Publicado 2023

Loss of anti‐spike antibodies following mRNA vaccination for COVID‐19 among patients with multiple myeloma

por Stampfer, Samuel D., Bujarski, Sean, Goldwater, Marissa‐Skye, Jew, Scott, Regidor, Bernard, Chen, Haiming, Xu, Ning, Li, Mingjie, Fung, Eddie, Swift, Regina, Beatty, Bethany, Eshaghian, Shahrooz, Berenson, James R.
Publicado 2023

Sars-Cov-2 Antibody Decay Monitoring in mRNA Vaccinated Multiple Myeloma Patients

por Stampfer, Samuel D., Goldwater, Marissa-Skye, Regidor, Bernard Sean S., Jew, Scott Kristian, Bujarski, Sean Elliott, Chen, Haiming, Yashar, David, Xu, Ning, Li, Mingjie, Green, Tracy, Fung, Eddie, Aquino, Elias, Swift, Regina, Eshaghian, Shahrooz, Feinstein, Aaron, Berenson, James R.
Publicado 2021

Response to mRNA vaccination for COVID-19 among patients with multiple myeloma

por Stampfer, Samuel D., Goldwater, Marissa-Skye, Jew, Scott, Bujarski, Sean, Regidor, Bernard, Daniely, David, Chen, Haiming, Xu, Ning, Li, Mingjie, Green, Tracy, Fung, Eddie, Aquino, Elias, Swift, Regina, Eshaghian, Shahrooz, Preugschat, Kurt, Feinstein, Aaron J., Spektor, Tanya M., Berenson, James R.
Publicado 2021